Document is current

Article History

Received: 22 January 2024

Accepted: 16 September 2024

First Online: 18 October 2024

Declarations

:

: The data application/protocol was submitted to and approved by the Independent Scientific Advisory Committee (ISAC) at the Clinical Practice Research Datalink (CPRD), and the linked data were prepared by the CPRD.

: AB received support for the present publication from Astellas; received payment or honoraria for lectures, presentations, speakers bureaus, publication writing, or educational events from Astellas and Janssen; received research funding to their institution and support for attending meetings and/or travel from Janssen; and participated on an advisory board for Janssen. AC, AP, NR, RS, and KM are full-time employees of Astellas Pharma Europe Ltd., Surrey, UK. HS was a full-time employee of Astellas Pharma Europe Ltd., Surrey, UK, at the time of the study. DC received support for the present publication from Astellas. AM received support for the present publication from Astellas; received grants or contracts, consulting fees, payment, or honoraria for lectures, presentations, speakers bureaus, publication writing, or educational events, as well as support for attending meetings and/or travel from AstraZeneca, Astellas, Bayer, Bristol-Myers Squibb, Ferring, Ipsen, Janssen, EUSAPharm, MSD, Merck Serono, Novartis, Takeda, Teva, Pfizer, Recordati, and Roche; and holds leadership or fiduciary roles in the EAU and DGU boards of directors.